SCHEMBL8861573

SCHEMBL8861573

CCOC(=O)CCn1c(=O)n(C)c(=O)c2c1ncn2C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 5/20 0.82
▸ PDE4A P27815 7/20 0.65
▸ PDE4B Q07343 7/20 0.65
▸ PDE4C Q08493 7/20 0.65
▸ PDE4D Q08499 7/20 0.65
▸ ADORA2A P29274 4/20 0.65
▸ ADORA2B P29275 7/20 0.54
▸ CYP1A2 P05177 2/20 0.53
▸ PMP22 Q01453 2/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ ACHE P22303 2/20 0.51
▸ PIK3CD O00329 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ CNR1 P21554 1/20 0.51
▸ ADORA1 P30542 1/20 0.51
▸ NTSR1 P30989 1/20 0.51
▸ MC3R P41968 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5424162 0.83 TNF (1.00) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL6384593 0.82 TNF (1.00) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL17682312 0.82 TNF (1.00) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL6190255 0.80 TNF (0.76) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL21381247 0.80 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL17626126 0.79 ADORA2B (0.65) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL8861588 0.78 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL9765651 0.78 PDE4A (0.74) TNFPDE4APDE4BPDE4CPDE4D
Caffeine SCHEMBL28002404 0.78 ADORA2B (0.68) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL16697212 0.78 ADORA2A (0.79) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5620676-A ADENOSINE TRIPHOSPHATE DERIVATIVES; TREATMENT OF SEPTIC SHOCK OR BRAIN SEIZURES, LEARNING ENHANCEMENT THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-04-15 — — US disclosed
Send feedback